+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241341
  • Report
  • January 2021
  • Region: Middle East, Africa
  • 97 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • MORE
The Latin America, Middle East and Africa Antibiotics Market is expected to witness market growth of 6.2% CAGR during the forecast period (2020-2026).

Antibiotics are basically a combination of medicines that helps in curing infection caused by germs, bacteria, and some parasites. It kills all the infection-causing microorganisms. From the beginning of infectious diseases, till now, there have been numerous incidents of chronic and infectious diseases that are leading the growth of the antibiotic market. The growing prevalence of infectious diseases provides great opportunities for the companies, as antibiotics help in curing these infectious diseases. Therefore, it further accelerates the growth of the market.

The increasing incidents of chronic and infectious diseases around the globe and the properties of antibiotics to treat the broad spectrum of bacterial infections will propel the growth of the antibiotic market. There are many companies that are implementing some strategic plans of collaborative development programs to cut down their expenses. These plans will help the companies to develop more molecules. Further, the public-private collaborations, where funds and unique R&D approaches are adopted by public bodies and antibiotics manufacturers, will assist the creation of the latest and modern pipeline products.

The collaborative development efforts help the companies to widen up their range of products. It also encourages them to develop innovative and advanced solutions, which further support the growth of the antibiotic market.

Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.

Scope of the Study

Market Segments covered in the Report:

By Action Mechanism
  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors,
  • Mycolic Acid Inhibitors
By Drug Class
  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides,
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antibiotics Market, by Action Mechanism
1.4.2 LAMEA Antibiotics Market, by Drug Class
1.4.3 LAMEA Antibiotics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Jul) Leading Players

Chapter 4. LAMEA Antibiotics Market by Action Mechanism
4.1 LAMEA Cell Wall Synthesis Inhibitors Market by Country
4.2 LAMEA Protein Synthesis Inhibitors Market by Country
4.3 LAMEA DNA Synthesis Inhibitors Market by Country
4.4 LAMEA RNA Synthesis Inhibitors Market by Country
4.5 LAMEA Others Market by Country

Chapter 5. LAMEA Antibiotics Market by Drug Class
5.1 LAMEA Cephalosporin Market by Country
5.2 LAMEA Penicillin Market by Country
5.3 LAMEA Fluoroquinolone Market by Country
5.4 LAMEA Macrolides Market by Country
5.5 LAMEA Carbapenem Market by Country
5.6 LAMEA Aminoglycosides Market by Country
5.7 LAMEA Sulfonamides Market by Country
5.8 LAMEA Others Market by Country

Chapter 6. LAMEA Antibiotics Market by Country
6.1 Brazil Antibiotics Market
6.1.1 Brazil Antibiotics Market by Action Mechanism
6.1.2 Brazil Antibiotics Market by Drug Class
6.2 Argentina Antibiotics Market
6.2.1 Argentina Antibiotics Market by Action Mechanism
6.2.2 Argentina Antibiotics Market by Drug Class
6.3 UAE Antibiotics Market
6.3.1 UAE Antibiotics Market by Action Mechanism
6.3.2 UAE Antibiotics Market by Drug Class
6.4 Saudi Arabia Antibiotics Market
6.4.1 Saudi Arabia Antibiotics Market by Action Mechanism
6.4.2 Saudi Arabia Antibiotics Market by Drug Class
6.5 South Africa Antibiotics Market
6.5.1 South Africa Antibiotics Market by Action Mechanism
6.5.2 South Africa Antibiotics Market by Drug Class
6.6 Nigeria Antibiotics Market
6.6.1 Nigeria Antibiotics Market by Action Mechanism
6.6.2 Nigeria Antibiotics Market by Drug Class
6.7 Rest of LAMEA Antibiotics Market
6.7.1 Rest of LAMEA Antibiotics Market by Action Mechanism
6.7.2 Rest of LAMEA Antibiotics Market by Drug Class

Chapter 7. Company Profiles
7.1 GlaxoSmithKline PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Product Launches and Product Expansions:
7.3.1.2 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent strategies and developments:
7.4.4.1 Acquisition and Mergers:
7.4.4.2 Product Launches and Product Expansions:
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Novartis AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.5.2 Partnerships, Collaborations, and Agreements:
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Eli Lilly and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll